SCHEMBL23948693

SCHEMBL23948693

CNC(=O)c1cc(C)c(N)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.46
PIK3CA P42336 1/20 0.38
MTOR P42345 1/20 0.38
CFTR P13569 2/20 0.38
CYP1A2 P05177 2/20 0.37
HDAC1 Q13547 7/20 0.36
BRAF P15056 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
MAPK1 P28482 2/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
GPR27 Q9NS67 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HDAC6 Q9UBN7 4/20 0.35
IKBKB O14920 1/20 0.35
ALDH1A1 P00352 2/20 0.34
ALOX15 P16050 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29501882 1.00 GAA (0.46) GAAPIK3CAMTORCFTRCYP1A2
SCHEMBL15939166 0.93 GAA (0.46) GAAPIK3CAMTORCFTRCYP1A2
SCHEMBL29502073 0.88 GAA (0.35) GAAPIK3CAMTORCYP1A2HDAC1
SCHEMBL31473552 0.86 GAA (0.46) GAAPIK3CAMTORCFTRCYP1A2
SCHEMBL13575596 0.85 GAA (0.48) GAAPIK3CAMTORCFTRHDAC1
SCHEMBL2868028 0.81 GAA (0.48) GAAPIK3CAMTORCFTRHDAC1
SCHEMBL12506962 0.79 GAA (0.50) GAAHDAC1HDAC6
SCHEMBL15042789 0.79 KDM4E (0.46) GAAMAPK1CYP3A4TSHRMAPT
SCHEMBL23618692 0.79 DGAT1 (0.48) CYP1A2MAPK1CYP3A4TSHRMAPT
SCHEMBL1203927 0.79 GAA (0.50) GAACFTRHDAC1BRAFALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114315834-B Imidazolone derivatives and their use in medicine 成都百裕制药股份有限公司 2024-01-05 CN disclosed
US-20230165867-A1 IMIDAZOLIDINONE DERIVATIVES AND MEDICAL USE THEREOF KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (CN) 2023-06-01 US disclosed
US-20230165867-A1 IMIDAZOLIDINONE DERIVATIVES AND MEDICAL USE THEREOF KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (CN) 2023-06-01 US disclosed
EP-4137491-A1 IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE Chengdu Baiyu Pharmaceutical Co., Ltd. (CN) 2023-02-22 EP disclosed
EP-4137491-A1 IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE Chengdu Baiyu Pharmaceutical Co., Ltd. (CN) 2023-02-22 EP disclosed
CN-114315834-A Imidazolidinone derivatives and their use in medicaments 成都百裕制药股份有限公司 2022-04-12 CN disclosed
WO-2021209055-A1 IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE 成都百裕制药股份有限公司 2021-10-21 WO disclosed
WO-2021209055-A1 IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE 成都百裕制药股份有限公司 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165867-A1 IMIDAZOLIDINONE DERIVATIVES AND MEDICAL USE THEREOF SYMPK, PAICS, CYP2C9 GAA 2222/4885PIK3CA 238/4885MTOR 295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.